{"id":"W2955483855","doi":"10.1007/s40744-019-0165-3","title":"Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis","year":2019,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"School of Medicine; University of Utah; Genentech; Celgene; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company; KU Leuven; U.S. Department of Veterans Affairs","keywords":"Ixekizumab; Medicine; Ankylosing spondylitis; Placebo; Physical therapy; Repeated measures design; Internal medicine; Clinical trial; Clinical endpoint; Secukinumab; Disease; Psoriatic arthritis; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08010166,0.0005952842,0.001771048,0.0009335477,0.0003483284,0.002087314,0.0005985324,0.0007055763,0.002333557],"category_scores_gemma":[0.1054825,0.0003716339,0.00234807,0.001972303,0.0008316697,0.001022372,0.001420672,0.001046957,0.0003481833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008248204,"about_ca_system_score_gemma":0.002476589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004776161,"about_ca_topic_score_gemma":0.000535201,"domain_scores_codex":[0.9366619,0.04716707,0.00772809,0.003043614,0.004715323,0.0006840048],"domain_scores_gemma":[0.9211498,0.04753044,0.02133752,0.003231345,0.005405031,0.001345822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2013019,0.001979048,0.4201328,0.01398843,0.02203194,0.0001263034,0.001905611,0.005603175,0.004459634,0.00157342,0.008142309,0.3187554],"study_design_scores_gemma":[0.06364156,0.05140039,0.8390359,0.002763792,0.0133739,0.0003242905,0.0005582479,0.007762851,0.003942474,0.002517614,0.01452642,0.0001526051],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.943475,0.03264406,0.005597612,0.003353955,0.0007992858,0.003796461,0.003861349,0.0001758486,0.006296495],"genre_scores_gemma":[0.9849423,0.002280257,0.005795618,0.000777603,0.0003343571,0.003743583,0.001602272,0.00003649207,0.0004873965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08010166,"threshold_uncertainty_score":0.4236231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04098222901732711,"score_gpt":0.3942169106277126,"score_spread":0.3532346816103855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}